150 related articles for article (PubMed ID: 37218317)
1. [Hematologic Malignancies/Pediatric Malignancies Rave Types of B-Cell Lymphoma].
Yano S
Gan To Kagaku Ryoho; 2023 May; 50(5):589-590. PubMed ID: 37218317
[No Abstract] [Full Text] [Related]
2. Chimeric antigen receptor natural killer cells for the treatment of patients with B-cell malignancies.
Rezvani K
Clin Adv Hematol Oncol; 2020 Sep; 18(9):543-545. PubMed ID: 33006583
[No Abstract] [Full Text] [Related]
3. Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes.
Roselli E; Faramand R; Davila ML
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463538
[TBL] [Abstract][Full Text] [Related]
4. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():390-4. PubMed ID: 17474435
[No Abstract] [Full Text] [Related]
5. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
Weingart O; Rehan FA; Schulz H; Naumann F; Knauel I; Bohlius CB; Engert A
J Natl Cancer Inst; 2007 Sep; 99(17):E1. PubMed ID: 17728205
[No Abstract] [Full Text] [Related]
6. Vaccine therapy of B cell malignancies: different strategies for a novel approach.
Liso A; Benedetti R; Flenghi L; Falini B
Leuk Lymphoma; 2001; 42(5):881-9. PubMed ID: 11697643
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic vaccination in B-cell malignancies.
Bianchi A; Massaia M
Mol Med Today; 1997 Oct; 3(10):435-41. PubMed ID: 9358470
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR.
Pelcovits A; Pandita A; Farmakiotis D; Egan P
Leuk Res; 2021 Jan; 100():106473. PubMed ID: 33285314
[No Abstract] [Full Text] [Related]
10. Unusual presentations of hematologic malignancies: CASE 3. Primary central nervous system B-cell lymphoma of marginal zone B-cell type in a neurosyphilis patient.
Haque B; Gotlib V; Bolla S; Bloomfield K; Patel A
J Clin Oncol; 2004 Apr; 22(7):1333-5. PubMed ID: 15051783
[No Abstract] [Full Text] [Related]
11. CAR T-Cell Therapy in Hematologic Malignancies: Clinical Role, Toxicity, and Unanswered Questions.
Gill S; Brudno JN
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-20. PubMed ID: 33989023
[TBL] [Abstract][Full Text] [Related]
12. Imaging Musculoskeletal Manifestations of Pediatric Hematologic Malignancies.
Tannenbaum MF; Noda S; Cohen S; Rissmiller JG; Golja AM; Schwartz DM
AJR Am J Roentgenol; 2020 Feb; 214(2):455-464. PubMed ID: 31799868
[No Abstract] [Full Text] [Related]
13. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
14. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Cutaneous Hematologic Disorders: Cutaneous Lymphoma and Leukemia Cutis-Experience of a Tertiary-Care Pediatric Institution and Review of the Literature.
Colmant C; Demers MA; Hatami A; Coulombe J; McCuaig CC; Piram M; Marcoux D; Kokta V; Powell J
J Cutan Med Surg; 2022; 26(4):349-360. PubMed ID: 35167768
[TBL] [Abstract][Full Text] [Related]
16. Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells.
Cheadle EJ; Hawkins RE; Batha H; Rothwell DG; Ashton G; Gilham DE
J Immunother; 2009 Apr; 32(3):207-18. PubMed ID: 19242379
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma.
Ayuk F; Zander A; Kröger N
Ann Hematol; 2009 May; 88(5):401-4. PubMed ID: 19172273
[TBL] [Abstract][Full Text] [Related]
18. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
19. Harnessing immunotherapy for pediatric T-cell malignancies.
Diorio C; Teachey DT
Expert Rev Clin Immunol; 2020 Apr; 16(4):361-371. PubMed ID: 32103690
[TBL] [Abstract][Full Text] [Related]
20. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC
Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
